Favipiravir inconclusive in COVID-19 patients in Japan

Favipiravir inconclusive in COVID-19 patients in Japan
  • Clock-gray 10:56
  • calendar-gray 10 July 2020

A clinical trial of Fujifilm Holdings Corp's Avigan drug yielded inconclusive results as a treatment of COVID-19, Japanese researchers said on Friday, APA reports citing Reuters.

Although patients given the drug early in the trial showed more improvement than those who got delayed doses, the results did not reach statistical significance, Fujita Health University researcher Yohei Doi said.

The results, announced at a news conference on Friday, followed the completion of a clinical trial conducted between March and May on 89 patients across Japan.

apa-logo-mini

Other news